Pyrogallol

Pyrogallol is a phenolic acid compound that serves as a plant metabolite and chemical intermediate in synthetic processes. It functions as a phenolic donor in microbial metabolic pathways but lacks documented therapeutic applications in humans.

Origin & History

Pyrogallol is a benzenetriol, an organic compound with three hydroxyl groups on a benzene ring. It is produced by decarboxylating gallic acid, traditionally sourced from tannic acids in nutgalls and Tara powder.

Historical & Cultural Context

Pyrogallol's production method was first reported by Scheele in 1786, focusing on chemical discovery rather than traditional medicinal use. There is no documented historical use in traditional medicine systems.

Health Benefits

• No clinical evidence of health benefits in human studies has been identified in the research.
• The compound's roles are described in synthetic chemistry contexts.
• Pyrogallol is noted as a plant metabolite.
• It acts as a phenolic donor in microbial pathways.
• Lacks documented therapeutic applications in humans.

How It Works

Pyrogallol acts as a phenolic donor through its three hydroxyl groups, participating in electron transfer reactions and antioxidant processes in plant and microbial systems. The compound can undergo oxidation to form quinones and participate in redox cycling reactions. In laboratory settings, it serves as a reducing agent and oxygen scavenger through its polyphenolic structure.

Scientific Research

The research dossier lacks peer-reviewed clinical trials or meta-analyses evaluating the efficacy of pyrogallol in humans. No PMIDs for human studies are available.

Clinical Summary

No clinical trials evaluating pyrogallol's health benefits in humans have been identified in the scientific literature. The available research focuses primarily on its chemical properties and synthetic applications rather than therapeutic effects. Studies examining pyrogallol are limited to in vitro chemical analyses and its role as an industrial chemical intermediate. Current evidence does not support any health claims for pyrogallol supplementation.

Nutritional Profile

Pyrogallol (benzene-1,2,3-triol; C₆H₃(OH)₃; MW 126.11 g/mol) is a polyphenolic compound, not a nutritional food source. It is not consumed as a dietary supplement or food ingredient due to its known toxicity. Key details: • Bioactive classification: Simple trihydroxybenzene (a phenolic compound with three adjacent hydroxyl groups on the benzene ring). • Natural occurrence: Found in trace amounts as a plant metabolite; produced via decarboxylation of gallic acid (e.g., by microbial enzymes such as gallate decarboxylase). Present in small quantities in certain plant extracts, tea leaves (as a degradation product of gallotannins), and some fermented products. Estimated concentrations in natural sources are typically in the low µg/g to mg/g range depending on the matrix. • Macronutrients: Not applicable — pyrogallol is not a food and provides no caloric, protein, fat, or carbohydrate value. • Vitamins/Minerals/Fiber: None. • Bioactive properties (in vitro only): Exhibits strong reducing/antioxidant capacity (ORAC and FRAP assays show high radical-scavenging activity due to the 1,2,3-trihydroxy arrangement); however, it also readily auto-oxidizes in the presence of O₂ to generate superoxide radicals (O₂⁻•) and hydrogen peroxide, making it a well-known pro-oxidant. • Bioavailability notes: Rapidly absorbed in the gastrointestinal tract in animal models; undergoes extensive Phase II metabolism (glucuronidation, sulfation, and methylation) in the liver and intestinal epithelium. The major circulating metabolites include methylated forms (e.g., 1-O-methylpyrogallol, 2-O-methylpyrogallol) and their glucuronide/sulfate conjugates. Free pyrogallol has very limited systemic bioavailability due to first-pass metabolism. Half-life in plasma is short (minutes to low hours in rodent models). • Toxicity concern: Pyrogallol is classified as toxic (LD₅₀ oral, rat: ~300–400 mg/kg). It causes hemolytic anemia, hepatotoxicity, and nephrotoxicity at relatively low doses, which precludes its use as a dietary or therapeutic agent. • Relevance to human nutrition: Pyrogallol is encountered primarily as a microbial metabolite of dietary gallotannins and gallic acid in the human gut (produced by gut microbiota at estimated nanomolar to low micromolar concentrations in the colonic lumen), but it is not itself a nutrient or recognized bioactive dietary compound with beneficial nutritional value.

Preparation & Dosage

No clinically studied dosage ranges for pyrogallol in humans are documented. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Gallic acid, tannic acid, catechin, quercetin, resveratrol

Safety & Interactions

Pyrogallol is primarily recognized as an industrial chemical and photographic developer rather than a dietary supplement. Direct exposure can cause skin and mucous membrane irritation due to its reducing properties. No established safe dosage ranges exist for human consumption, and the compound is not approved as a food additive or dietary supplement. Pregnant and nursing women should avoid exposure due to lack of safety data.